Indeloxazine
Indeloxazine
Indeloxazine (pronounced in-del-ox-a-zine) is a pharmacological agent that was primarily used in Japan for the treatment of cerebrovascular disorders and related conditions. It was developed by Yamanouchi Pharmaceutical Co. and marketed under the brand name Elen]].
Etymology
The term "Indeloxazine" is derived from the chemical structure of the compound, which is an indole derivative with an oxazine ring.
Pharmacology
Indeloxazine is classified as a serotonin-norepinephrine reuptake inhibitor (SNRI), which means it increases the levels of serotonin and norepinephrine in the brain by inhibiting their reuptake into neurons. It also has neuroprotective and nootropic effects, which are thought to be due to its ability to enhance cerebral blood flow and oxygen supply.
Medical Uses
Indeloxazine was primarily used for the treatment of cerebrovascular disease, including stroke and transient ischemic attack (TIA). It was also used for the management of dementia and other cognitive disorders, as well as for the treatment of depression and anxiety disorders.
Related Terms
- Serotonin-norepinephrine reuptake inhibitor
- Cerebrovascular disease
- Stroke
- Transient ischemic attack
- Dementia
- Depression
- Anxiety
See Also
External links
- Medical encyclopedia article on Indeloxazine
- Wikipedia's article - Indeloxazine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski